A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
Virogen Biotechnology Inc.
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Prescient Therapeutics, Ltd.
Memorial Sloan Kettering Cancer Center
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
Columbia University
Mayo Clinic
Soligenix
Icahn School of Medicine at Mount Sinai
Stanford University
City of Hope Medical Center
Thomas Jefferson University
University College, London
Innate Pharma
4SC AG
Northwestern University
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
University of Nebraska
Eastern Cooperative Oncology Group
Soligenix
Genmab
OncoSec Medical Incorporated
Genmab
Mayo Clinic
miRagen Therapeutics, Inc.
Rochester Skin Lymphoma Medical Group, PLLC
European Organisation for Research and Treatment of Cancer - EORTC
Novartis
Novartis
Rochester General Hospital
Fred Hutchinson Cancer Center
Northwestern University
miRagen Therapeutics, Inc.
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
National Cancer Institute (NCI)